- Home
- ANTX vs NCO Comparison
ANTX vs NCO Comparison
Compare ANTX & NCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANTX | NCO |
|---|---|---|
| Founded | 2017 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.9M | 146.0M |
| IPO Year | 2022 | 2026 |
Fundamental Metrics
Financial Performance| Metric | ANTX | NCO |
|---|---|---|
| Price | $3.58 | $9.94 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 296.8K | 67.7K |
| Earning Date | 11-11-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $9.83 |
| 52 Week High | $7.19 | $9.96 |
Technical Indicators
Market Signals| Indicator | ANTX | NCO |
|---|---|---|
| Relative Strength Index (RSI) | 30.50 | 61.86 |
| Support Level | $3.21 | $9.90 |
| Resistance Level | $5.15 | N/A |
| Average True Range (ATR) | 0.31 | 0.01 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 19.73 | 66.67 |
Price Performance
Historical ComparisonAbout ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
About NCO Southern Cross Acquisition I Corp. Ordinary Shares
Southern Cross Acquisition I Corp is a blank check company formed for the purpose of effecting into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.